BG104436A - The administration of macrolides for the treatment of cancer and macular degeneration - Google Patents

The administration of macrolides for the treatment of cancer and macular degeneration

Info

Publication number
BG104436A
BG104436A BG104436A BG10443600A BG104436A BG 104436 A BG104436 A BG 104436A BG 104436 A BG104436 A BG 104436A BG 10443600 A BG10443600 A BG 10443600A BG 104436 A BG104436 A BG 104436A
Authority
BG
Bulgaria
Prior art keywords
administration
treatment
macular degeneration
macrolides
cancer
Prior art date
Application number
BG104436A
Other languages
Bulgarian (bg)
English (en)
Inventor
Yat Sun Or
Jacob Plattner
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of BG104436A publication Critical patent/BG104436A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
BG104436A 1997-10-31 2000-05-15 The administration of macrolides for the treatment of cancer and macular degeneration BG104436A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96147397A 1997-10-31 1997-10-31
PCT/US1998/023043 WO1999022722A2 (fr) 1997-10-31 1998-10-30 Utilisation de macrolides pour le traitement du cancer et de la degenerescence maculaire

Publications (1)

Publication Number Publication Date
BG104436A true BG104436A (en) 2000-12-29

Family

ID=25504514

Family Applications (1)

Application Number Title Priority Date Filing Date
BG104436A BG104436A (en) 1997-10-31 2000-05-15 The administration of macrolides for the treatment of cancer and macular degeneration

Country Status (17)

Country Link
EP (1) EP1027060A2 (fr)
JP (1) JP2001521891A (fr)
KR (1) KR20010031577A (fr)
CN (1) CN1278178A (fr)
AR (1) AR043071A1 (fr)
AU (1) AU1206799A (fr)
BG (1) BG104436A (fr)
BR (1) BR9813318A (fr)
CA (1) CA2307850A1 (fr)
HU (1) HUP0100012A3 (fr)
IL (1) IL135518A0 (fr)
NO (1) NO20002189L (fr)
PL (1) PL340604A1 (fr)
SK (1) SK6172000A3 (fr)
TR (1) TR200001147T2 (fr)
WO (1) WO1999022722A2 (fr)
ZA (1) ZA989885B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5037771B2 (ja) 2000-04-13 2012-10-03 バイオチカ テクノロジー リミテッド グリコシル化されたハイブリッド産物およびその産生方法と利用
EP1539157B1 (fr) 2002-09-18 2013-08-21 Trustees Of The University Of Pennsylvania Rapamycine pour utilisation dans l'inhibition ou la réduction de la neovascularisation choroidienne
US7091196B2 (en) 2002-09-26 2006-08-15 Rib-X Pharmaceuticals, Inc. Bifunctional heterocyclic compounds and methods of making and using same
US7354574B2 (en) 2002-11-07 2008-04-08 Advanced Ocular Systems Limited Treatment of ocular disease
CA2520732C (fr) 2003-03-28 2012-12-04 Sloan-Kettering Institute For Cancer Research Analogues de migrastatine et leurs utilisations
US7083802B2 (en) 2003-07-31 2006-08-01 Advanced Ocular Systems Limited Treatment of ocular disease
US7087237B2 (en) 2003-09-19 2006-08-08 Advanced Ocular Systems Limited Ocular solutions
US7083803B2 (en) 2003-09-19 2006-08-01 Advanced Ocular Systems Limited Ocular solutions
EP2716647A3 (fr) 2004-02-27 2014-08-20 Rib-X Pharmaceuticals, Inc. Composes Macrocycliques Et Leurs Procedes De Fabrication Et D'utilisation
CN1950388A (zh) * 2004-02-27 2007-04-18 瑞伯-X医药品有限公司 大环化合物以及其制作和使用方法
US8957056B2 (en) 2004-05-25 2015-02-17 Sloan-Kettering Instiute For Cancer Research Migrastatin analogs in the treatment of cancer
US8188141B2 (en) 2004-09-23 2012-05-29 Sloan-Kettering Institute For Cancer Research Isomigrastatin analogs in the treatment of cancer
BRPI0608152A2 (pt) 2005-02-09 2009-11-10 Macusight Inc formulações para tratamento ocular
CA2615990A1 (fr) 2005-07-18 2007-01-25 Minu, L.L.C. Neuro-protection/neuro-stimulation oculaire amelioree
US8470985B2 (en) 2005-08-24 2013-06-25 Rib-X Pharmaceuticals, Inc. Triazole compounds and methods of making and using the same
US8278281B2 (en) 2005-08-24 2012-10-02 Rib-X Pharmaceuticals, Inc. Triazole compounds and methods of making and using the same
CA2635797C (fr) 2006-02-09 2015-03-31 Macusight, Inc. Formulations stables et leurs procedes de preparation et d'utilisation
WO2007112052A2 (fr) 2006-03-23 2007-10-04 Macusight, Inc. Formulations et méthodes destinées aux maladies ou aux pathologies liées à la perméabilité vasculaire
CN106317146B (zh) * 2015-06-18 2019-06-21 沈阳药科大学 双环克拉霉素衍生物及其作为肿瘤细胞增值抑制剂的用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6461090A (en) * 1989-10-30 1991-05-02 Abbott Laboratories Injectable formulation for lipophilic drugs
US5498424A (en) * 1994-11-30 1996-03-12 Klein; Ira Method of treating obesity

Also Published As

Publication number Publication date
KR20010031577A (ko) 2001-04-16
JP2001521891A (ja) 2001-11-13
HUP0100012A2 (hu) 2001-05-28
CN1278178A (zh) 2000-12-27
WO1999022722A3 (fr) 1999-08-05
HUP0100012A3 (en) 2003-07-28
EP1027060A2 (fr) 2000-08-16
TR200001147T2 (tr) 2000-08-21
NO20002189L (no) 2000-06-28
ZA989885B (en) 1999-05-05
WO1999022722A2 (fr) 1999-05-14
BR9813318A (pt) 2000-08-22
AR043071A1 (es) 2005-07-20
CA2307850A1 (fr) 1999-05-14
NO20002189D0 (no) 2000-04-27
IL135518A0 (en) 2001-05-20
SK6172000A3 (en) 2001-03-12
PL340604A1 (en) 2001-02-12
AU1206799A (en) 1999-05-24

Similar Documents

Publication Publication Date Title
BG104436A (en) The administration of macrolides for the treatment of cancer and macular degeneration
GEP20033025B (en) 4,4-Biarylpiperidine Derivatives with Opioid Receptor Activity
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
TR200200717T2 (tr) Terapötik kinazolin türevleri.
CA2275889A1 (fr) Preparation et methode de traitement de neoplasmes par inhalation
CA2258548A1 (fr) Derives tricycliques substitues par phenylamino, destines au traitement des maladies hyperproliferatives
MY127082A (en) Synergistic methods and compositions for treating cancer
CA2301057A1 (fr) Procede permettant d'administrer un taxane liposomal encapsule
EP1033981A4 (fr) Formulations et procedes de reduction de la toxicite d'agents antineoplasiques
HK1039328A1 (en) Pyrazolopyrimidinone derivatives for the treatment of impotence
HUP0204519A3 (en) 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity, pharmaceutical compositions containing them and process for their preparations
GEP20033140B (en) Substituted Bicyclic Derivatives Useful as Anticancer Agents
BG103417A (en) Condensed pyrimidine bicyclic derivatives
HUP0203238A3 (en) Drugs for the treatment of malignant tumours, process for their preparation and pharmaceutical compositions containing them
AU678344B2 (en) Lipophilic oligosaccharide antibiotic salt compositions
PL342614A1 (en) Anticarcinogenic drugs
HUT64013A (en) Process for producing hiv-inhibiting phenylacetamide derivatives and pharmaceutical compositions comprising such compounds as active ingredient
ZA937558B (en) New taxane derivatives, their preparation and pharmaceutical compositions which contain them
IL136733A0 (en) Pharmaceutical composition containing sibutramine and orlistat
GB9907571D0 (en) Compounds
HUT73529A (en) New bis-naphthalimides for the treatment of cancer
IL165086A (en) Pyridyl cyanoguanidines, pharmaceutical compositions comprising them and uses thereof for the preparation of medicaments
BG106180A (en) Pharmaceutical composition containing sibutramine and orlistat
GEP20032975B (en) Echinocandin Derivatives, Preparation Method and Pharmaceutical Composition
BG106831A (en) Compound and method for the treatment of pain